Teleflex Inc. (NYSE:TFX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

According to Zacks, “Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex was founded in 1943 and is headquartered in Wayne, Pennsylvania. “

Several other research firms have also recently weighed in on TFX. Leerink Swann raised their target price on shares of Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Jefferies Group raised their target price on shares of Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a research note on Friday, July 29th. Barclays PLC raised their target price on shares of Teleflex from $183.00 to $185.00 and gave the company an “overweight” rating in a research note on Friday, July 29th. Finally, Stephens cut shares of Teleflex from an “overweight” rating to an “equal weight” rating in a research note on Friday, October 28th. Four equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. Teleflex presently has an average rating of “Buy” and a consensus target price of $171.33.

Analyst Recommendations for Teleflex (NYSE:TFX)

Shares of Teleflex (NYSE:TFX) opened at 153.19 on Friday. Teleflex has a 1-year low of $125.28 and a 1-year high of $188.79. The company has a market capitalization of $6.75 billion, a P/E ratio of 26.46 and a beta of 0.88. The firm has a 50-day moving average of $154.04 and a 200 day moving average of $169.28.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 27th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.78 by $0.02. The firm earned $455.60 million during the quarter, compared to analysts’ expectations of $461.80 million. Teleflex had a net margin of 15.09% and a return on equity of 15.66%. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.60 earnings per share. On average, analysts anticipate that Teleflex will post $7.30 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Tuesday, November 15th will be issued a $0.34 dividend. The ex-dividend date is Thursday, November 10th. This represents a $1.36 annualized dividend and a dividend yield of 0.89%. Teleflex’s dividend payout ratio (DPR) is presently 23.49%.

COPYRIGHT VIOLATION NOTICE: “Zacks Investment Research Upgrades Teleflex Inc. (TFX) to Hold” was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2016/11/26/zacks-investment-research-upgrades-teleflex-inc-tfx-to-hold.html.

Several large investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its stake in Teleflex by 8.4% in the first quarter. Envestnet Asset Management Inc. now owns 6,684 shares of the medical technology company’s stock valued at $1,049,000 after buying an additional 519 shares during the period. Metropolitan Life Insurance Co. NY raised its stake in Teleflex by 3.0% in the first quarter. Metropolitan Life Insurance Co. NY now owns 37,721 shares of the medical technology company’s stock valued at $5,923,000 after buying an additional 1,085 shares during the period. Arizona State Retirement System raised its stake in Teleflex by 4.3% in the first quarter. Arizona State Retirement System now owns 21,624 shares of the medical technology company’s stock valued at $3,395,000 after buying an additional 900 shares during the period. BlueMountain Capital Management LLC purchased a new stake in Teleflex during the first quarter valued at about $224,000. Finally, CenturyLink Investment Management Co purchased a new stake in Teleflex during the second quarter valued at about $334,000. Hedge funds and other institutional investors own 94.49% of the company’s stock.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

5 Day Chart for NYSE:TFX

Receive News & Stock Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related stocks with our FREE daily email newsletter.